Gambia: MCA Reports 121 Medical Products Failed Quality Tests in 2024
[Foroyaa] A total of 121 medical products failed post-shipment quality testing in 2024, according to the Medicines Control Agency (MCA).
According to the Medicines Control Agency (MCA) of The Gambia, 121 medical products failed post-shipment quality testing in 2024. This is detailed in the agency's 2024 activity report, which was presented to The Gambia's National Assembly for review. The MCA tested 281 products throughout the year, with 247 originating from India, 27 from Ghana, and seven from Pakistan.
Of these, 192 from India, 23 from Ghana, and all seven from Pakistan met post-shipment quality standards. The failure rates stood at 22.3% for Indian products, 14.8% for Ghanaian products, and 0% for Pakistani products, resulting in an overall failure rate of 22.1%. The report highlights that India was the primary source of product failures, accounting for 55 out of the 62 failures, or 88.7% of them.
Products from Pakistan were found to be fully compliant, while Ghana had a lower failure rate than India. The MCA emphasized the continued significance of both pre-shipment and post-shipment testing in ensuring product safety and public health.
Written by urgent.news from AllAfrica Health's reporting — not their text. Machine-written; read the original for the full account.
